Skip to content
OpenFederal grantOpen to for-profit businessesRFA-EB-28-004

NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

National Institutes of HealthCloses Dec 1, 2030(1499 days left)

Does this fit your business?

This NIH R18 program funds translational development of next-generation diagnostic and therapeutic devices serving the BRAIN and HEAL initiative missions, taking technologies up to readiness for first-in-human trials. It is for device developers with proof-of-concept results already in hand; clinical trials are not allowed. Retail, finance, housing, and any business outside medical device R&D should not bother applying.

Best for
Small businesses developing diagnostic or therapeutic devices, Universities and research institutions, Nonprofits doing device R&D, Tribal and government entities with relevant research programs
Not for
Retail, finance, or housing businesses, Companies without preliminary proof-of-concept device work, Applicants planning clinical trials
Estimated fit by industry, best first
IndustryEstimated fit
Healthcare & BiotechMatches your industry (clinical)
89
Strong Match
Technology & SoftwareMatches your industry (technology, tech)
86
Strong Match
Agriculture & FarmingLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Arts & CultureLimit: Nothing in this notice points to arts & culture
54
Possible Match
Construction & InfrastructureLimit: Not clearly about your industry or what you need funding for; check the…
54
Possible Match
Education & TrainingLimit: Nothing in this notice points to education & training
54
Possible Match
Show all 15 industries
Estimated fit by industry, best first
IndustryEstimated fit
Energy & Clean TechLimit: Nothing in this notice points to energy & clean tech
54
Possible Match
Environment & ConservationLimit: Nothing in this notice points to environment & conservation
54
Possible Match
Finance & BankingLimit: Nothing in this notice points to finance & banking
54
Possible Match
Food & BeverageLimit: Nothing in this notice points to food & beverage
54
Possible Match
Housing & Real EstateLimit: Nothing in this notice points to housing & real estate
54
Possible Match
ManufacturingLimit: Nothing in this notice points to manufacturing
54
Possible Match
Retail & E-CommerceLimit: Nothing in this notice points to retail & e-commerce
54
Possible Match
Social Services & NonprofitLimit: Nothing in this notice points to social services & nonprofit
54
Possible Match
Transportation & LogisticsLimit: Nothing in this notice points to transportation & logistics
54
Possible Match

These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.

What this funds

Money can be used for
R&D, Research, Technical assistance
Who can apply
Small businesses, For-profit companies, Nonprofits, State and local governments, Tribal governments and organizations, Colleges and universities, Other applicants (see eligibility)

Questions about this grant

When is the application deadline?
The application deadline is December 1, 2030.
How much funding can an applicant receive?
Total program funding is $6,000,000, with about 4 awards expected. The facts do not state a per-award amount.
Who can apply for this grant?
Eligible applicants include small businesses, for-profit organizations other than small businesses, nonprofits with and without 501(c)(3) status, public and private institutions of higher education, state, local, and tribal governments, independent school districts, public housing authorities, and other organizations listed in the eligibility text, including federal agencies, U.S. territories, faith-based and community organizations, regional organizations, and foreign institutions.
Can a sole proprietor or single-member LLC apply?
The facts do not specifically address sole proprietors or single-member LLCs. Small businesses and for-profit organizations generally are listed as eligible, so check the full NOFO eligibility text for your business structure.
Can a nonprofit apply?
Yes. Nonprofits with 501(c)(3) status and nonprofits without 501(c)(3) status (other than institutions of higher education) are both listed as eligible.

Summary

NIH R18 cooperative program funding translational development of next-generation diagnostic and therapeutic devices for BRAIN and HEAL initiative missions, advancing technologies to readiness for first-in-human trials. Eligible applicants include small businesses, for-profits, nonprofits, universities, tribal and state/local governments, and other organizations; clinical trials not allowed.

About this grant

This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to advance the development and translation of next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and The Helping to End Addiction Long-term (HEAL) Initiatives. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.

Who can apply

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Topics and uses of funds

Topics

  • Health
  • Science
  • Technology

Program contact

National Institutes of HealthNIBIB_Devices@NIH.gov301-402-2541

Open opportunities funding similar work, from the same funder or in the same place.

  • OpenFederal grantOpen to businesses

    HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)

    NIH HEAL Initiative phased R61/R33 mechanistic clinical research program to identify and validate multi-tissue biological mechanisms underlying joint pain and then test non-pharmacologic or multimodal interventions…

    Agency
    National Institutes of Health
    Deadline
    Closes Oct 30, 2026 · 6 days left
  • OpenFederal grantOpen to businesses

    GREGoRi Technology Integration Center (U01, Clinical Trials Optional)

    NIH funds one GREGoRi Technology Integration Center to develop standards, best practices, and benchmarking datasets for applying emerging molecular methods to rare genetic disease diagnosis. Eligible applicants include…

    Agency
    National Institutes of Health
    Deadline
    Closes Oct 30, 2026 · 6 days left
    Award
    Up to $2,250,000
  • OpenFederal grantOpen to businesses

    GREGoRi Innovation Projects (U01 Clinical Trial Optional)

    NIH GREGoRi innovation awards fund development and testing of highly innovative experimental or computational approaches to diagnose rare genetic diseases. Eligible applicants include small businesses, other…

    Agency
    National Institutes of Health
    Deadline
    Closes Oct 30, 2026 · 6 days left
    Award
    $3 – $500,000
  • OpenFederal grantOpen to businesses

    GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)

    NIH will fund one GREGoRi Data Coordination and Outreach Center (U01) to coordinate the rare-disease genomics program, harmonize protocols, and make data, metadata and computational tools available to the research…

    Agency
    National Institutes of Health
    Deadline
    Closes Oct 30, 2026 · 6 days left
    Award
    Up to $1,250,000